These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17693574)

  • 41. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ
    Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing.
    Kay E; O'Grady A; Morgan JM; Wozniak S; Jasani B
    J Clin Pathol; 2004 Nov; 57(11):1140-4. PubMed ID: 15509672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
    Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing HER2 assessment in breast cancer: application of automated image analysis.
    Holten-Rossing H; Møller Talman ML; Kristensson M; Vainer B
    Breast Cancer Res Treat; 2015 Jul; 152(2):367-75. PubMed ID: 26109345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One-day FISH approach for the high-speed determination of HER2 gene copy status in breast carcinoma.
    Hegyi K; Lønborg C; Mónus A; Méhes G
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):567-71. PubMed ID: 23455187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis.
    Barberis M; Pellegrini C; Cannone M; Arizzi C; Coggi G; Bosari S
    Am J Clin Pathol; 2008 Apr; 129(4):563-70. PubMed ID: 18343783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HER2 FISH in breast cancer.
    Bartlett JM; Forsyth A
    Methods Mol Med; 2004; 97():89-101. PubMed ID: 15064487
    [No Abstract]   [Full Text] [Related]  

  • 50. Simultaneous imaging of membrane antigen and the corresponding chromosomal locus in pathology archives.
    Igarashi H; Yamashita K; Suzuki M; Kitayama Y; Isogaki J; Maruyama K; Sunayama K; Tsuda H; Ozawa T; Kiyose S; Sugimura H
    Pathol Int; 2005 Dec; 55(12):753-6. PubMed ID: 16287489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of automated and manual analysis of interphase in situ hybridization signals in tissue sections and nuclear suspensions.
    Krijtenburg PJ; Alers JC; Bosman FT; van Dekken H
    Cytometry; 1996 Sep; 25(1):99-103. PubMed ID: 8875059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FISH detection of HER2 amplification in breast cancer.
    Mueller RE; O'Malley FP
    Methods Mol Biol; 2002; 204():353-67. PubMed ID: 12397809
    [No Abstract]   [Full Text] [Related]  

  • 53. Automatic detection of stable and unstable chromosome aberrations visualized by three-color imaging after fluorescence in situ hybridization with a painting and a pancentromeric DNA probe.
    Coco-Martin JM; Lolkus M; Ottenheim CP; Oomen LC; Blommestijn GJ; Begg AC
    Cytometry; 1998 Aug; 32(4):327-36. PubMed ID: 9701402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis.
    Fernández JL; Goyanes V; López-Fernández C; Buño I; Gosálvez J
    Cancer Genet Cytogenet; 1996 Jan; 86(1):18-21. PubMed ID: 8616779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.
    Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
    Diagn Pathol; 2013 Feb; 8():17. PubMed ID: 23379971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normalization of multicolor fluorescence in situ hybridization (M-FISH) images for improving color karyotyping.
    Wang YP; Castleman KR
    Cytometry A; 2005 Apr; 64(2):101-9. PubMed ID: 15729736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution.
    Beliën JA; Baak JP; van Diest PJ; van Ginkel AH
    Cytometry; 1997 Jun; 28(2):135-40. PubMed ID: 9181303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HER-2/neu analysis in breast cancer bone metastases.
    Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
    J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system.
    Stevens R; Almanaseer I; Gonzalez M; Caglar D; Knudson RA; Ketterling RP; Schrock DS; Seemayer TA; Bridge JA
    J Mol Diagn; 2007 Apr; 9(2):144-50. PubMed ID: 17384205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.
    McManus DT; Patterson AH; Maxwell P; Humphreys MW; Anderson NH
    Mol Pathol; 1999 Apr; 52(2):75-7. PubMed ID: 10474685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.